Gentian Anti-irritation Factor (2G) ：

专利工艺：独创的分离萃取技术

Patent technology: original extraction separation technology

药材可持续：选取西藏米拉山口4800米海拔，野生龙胆花，第二代龙胆抗刺激因子药材地道使用藏本草--龙胆花，提前一年采收地上部位，不对龙胆根进行破坏，保证龙胆花的可持续性（上海伽誉地道药材基地采收证明正在申请办理）

Herbs sustainable: Tibet milla mountain at an altitude of 4800 meters, wild gentiana flowers and herbs tunnel using the second generation of gentian of stimulating factor (Tibetan herbal medicine - gentian flowers, a year ahead of the ground area harvested, does not carry on gentian root damage, ensure sustainability of the gentian flowers (Shanghai gilgamesh reputation hongrentang base collecting proof is to apply for)

功效显著：5年基础研究，2篇发明专利，两项新型实用性专利

Efficacy significantly: 5 years of basic research, 2 invention patents, two new practical patent

产品功效临床应用2000例及第三方抗刺激抗炎测试。经过一年的市场应用，成为主流抗敏抗刺激原料，添加0.5%具有很好的防敏降低刺激效果，客户应用反馈，面膜每月300万片销售，仅有1-2个反应有过敏症状。结合小球藻深层净化因子使用具有很好抗敏修复激素脸效果。本产品以最高评分荣获2017年年度“中国十大创新原料”奖。

Product efficacy, 2000 cases of clinical application and the third party against stimulus anti-inflammatory test.After a year of market applications, mainstream anti-allergic resistance to stimulate the raw material, adding 0.5% has the very good prevent allergy to reduce the stimulation effect, customer feedback, mask 3 million sales a month, only one or two reactions have allergy symptoms.Chlorella deep purification factor using has the very good anti-allergic repair hormone face effect.This product with the highest score was awarded in 2017 "China's top ten innovative materials" of the year award.

龙胆抗刺激因子是一个真正意义上的产学研用一体化成果

Gentian Anti-irritation Factor (2G) is a real sense of the integration of production, with results.

药材筛选（周永传教授）

从事中药提取和分离工艺研究和实践三十多年，近四十年的研究生涯中对近几千种药材进行工艺开发和活性筛选，建立华东理工大学中药现代化工程中心，筛选出可以替代激素的植物性抗炎止痒祛红消肿植物--龙胆草。

工艺开发优化（蔡建国教授）

在周永传教授研究基础上对龙胆草提取工艺进行优化，利用华东理工大学化工学院现有技术对目标抗刺激抗炎成分进行最大程度的萃取，同时使用可食用溶剂，使产品极尽安全。

上海伽誉+国家藏药工程技术中心

上海伽誉生物科技有限公司对龙胆提取液进行市场调研，命名龙胆抗刺激因子，对其安全性，功效性（人体临床，动物模型）进行自验证和第三方验证；国家藏药工程技术中心对伽誉进行指导和帮助，拿到了地道的西藏龙胆草药材，产品升级二代：龙胆抗刺激因子（二代）

核心成分指标控制（陶黎明教授）

对独创工艺生产的龙胆提取液利用上海市化学生物学重点实验室设备及团队进行核心成分指标确认，找出目标功效核心成分--龙胆苦苷，并通过HPLC等设备标定其含量，已确认批次间产品稳定性和功效稳定性

上海伽誉+迪美新材料科研院

产品功效临床应用2000例及第三方抗刺激抗炎测试

Drug screening(Professor Yong-chuan Zhou)

Engaged in traditional Chinese medicine extraction and separation technology research and practice of more than 30 years, nearly 40 years of research careers in the nearly thousand kinds of medicinal materials technology development and the active filtering, to establish east China university of science and engineering center for TCM modernization, screening can replace hormone anti-inflammatory anti-itching remove red swelling plants, plant gentiana scabra bge.

Technological development optimization (Professor Jian-guo Cai)

On the basis of studying yong-chuan zhou professor of gentiana scabra bge to optimize the extraction process, using the existing technology of east China university of science and technology institute of chemical technology of target resistance to stimulate the anti-inflammatory ingredients maximum extraction, using edible solvent at the same time, make the product the best security.

Shanghai JAYU + National engineering center for medicine

Ogre reputation in ShanghaiJAYU to the market research of gentian extract, named Gentian Anti-irritation Factor (2G) , for its safety, efficacy of sex (human clinical, animal model) and third-party authentication;National engineering center for medicine to guide and help of ogre reputation, got the authentic Tibetan gentiana scabra bge medicinal materials, upgrade the second generation product: Gentian Anti-irritation Factor (2G) .

Core component index control (professor li-ming Tao)

Gentian extract of original production process using chemical biology key laboratory in Shanghai equipment core component index and team confirmed that find out the target function core ingredients - gentian bitter glycosides, and through HPLC equipment calibration, such as its content, stability, he said, has confirmed the product stability and efficacy

Shanghai JAYU+DIEMI

Product efficacy, 2000 cases of clinical application and the third party against stimulus anti-inflammatory test